Role of Complement Cascade in Glomerular Diseases
October 4, 2022 | Rare & Genetic Kidney Disease Drug Development Conference
Role of Complement Cascade in Glomerular Diseases
A potent anti-C5aR1 Antibody for Treatment of ANCA Associated Vasculitis
September 27, 2022 | Complement-based Drug Development Summit
A potent anti-C5aR1 Antibody for Treatment of ANCA Associated Vasculitis
Brief Human IL-2 Mutein Therapy Induces Foxp3+ T-Regulatory Cell Expansion and Donor-Specific Allograft Tolerance
June 4, 2022 | American Transplant Congress
Brief Human IL-2 Mutein Therapy Induces Foxp3+ T-Regulatory Cell Expansion and Donor-Specific Allograft Tolerance
A Novel IL-2 Mutein Selectively Expands Regulatory T Cells and Prolongs Skin Graft Survival
June 4, 2022 | American Transplant Congress
A Novel IL-2 Mutein Selectively Expands Regulatory T Cells and Prolongs Skin Graft Survival
Selective Regulatory T Cell Expansion by Novel IL-2 Mutein Prolongs Skin Transplant Survival
June 4, 2021 | American Transplant Congress
Selective Regulatory T Cell Expansion by Novel IL-2 Mutein Prolongs Skin Transplant Survival
Targeting C5aR1 for the Treatment of ANCA-associated Vasculitis
March 3, 2020 | Festival of Biologics
Targeting C5aR1 for the Treatment of ANCA-associated Vasculitis
Monovalent IgGs as a Tool for Characterizing Antibody Binding and Function
January 20, 2020 | Peptalk
Monovalent IgGs as a Tool for Characterizing Antibody Binding and Function
Leveraging Computational Approaches in Antibody Workflows: Discovery, Design and Engineering
September 17, 2019 | Discovery on target
Leveraging Computational Approaches in Antibody Workflows: Discovery, Design and Engineering
A Global Randomized, Double-Blind, Placebo-Controlled Study Evaluating Safety And Efficacy Of Vis410 In Combination With Oseltamivir Versus Oseltamivir Alone In Hospitalized Adults With Influenza A Requiring Oxygen
August 28, 2019 | International Society for Influenza and Respiratory Viruses (ISIRV) 'OPTIONS X' Conference
A Global Randomized, Double-Blind, Placebo-Controlled Study Evaluating Safety And Efficacy Of Vis410 In Combination With Oseltamivir Versus Oseltamivir Alone In Hospitalized Adults With Influenza A Requiring Oxygen
VIS410, A Broad-Spectrum Anti-Influenza A Monoclonal Antibody Neutralized Baloxovir Resistant Influenza A Virus In-Vitro
August 28, 2019 | International Society for Influenza and Respiratory Viruses (ISIRV) 'OPTIONS X' Conference
